36800-710 : Bismuth Subsalicylate 262 mg Oral Capsule, Gelatin Coated


NDC: 36800-710
Labeler: Topco Associates LLC
Product Type: Human OTC Drug
Drug Name:  Bismuth Subsalicylate
Dosage Form: Oral Capsule, Gelatin Coated
Application #: part335
Rev. Date: 


NDC Package Codes:

  • 36800-710-24: 2 BLISTER PACK IN 1 CARTON (36800‑710‑24) > 12 CAPSULE, GELATIN COATED IN 1 BLISTER PACK

Active Ingredients:

  • Bismuth Subsalicylate

Dosage Strength:

  • 262 mg

Related Products:

Based on records with the same trade name.
  • 0536-4301 Bismuth Subsalicylate 262 mg Oral Tablet by Rugby Laboratories Inc.
  • 62211-046 Bismuth Subsalicylate 262 mg Chewable Tablet by A&z Pharmaceutical, Inc.
  • 68071-4523 Bismuth Subsalicylate 262 mg Oral Tablet, Chewable by Nucare Pharmaceuticals, Inc.
  • 68210-4152 Bismuth Subsalicylate 262 mg Oral Capsule, Gelatin Coated by Spirit Pharmaceuticals LLC
  • 68210-5018 Bismuth Subsalicylate 262 mg Oral Capsule, Gelatin Coated by Spirit Pharmaceuticals LLC
  • 69168-999 Bismuth Subsalicylate 262 mg Oral Tablet, Chewable by Allegiant Health
  • 69842-346 Bismuth Subsalicylate 262 mg Oral Tablet, Film Coated by Cvs Pharmacy, Inc.
  • 69842-799 Bismuth Subsalicylate 262 mg Oral Capsule, Gelatin Coated by Cvs Pharmacy, Inc.
  • 70000-0594 Bismuth Subsalicylate 262 mg Oral Tablet, Film Coated by Cardinal Health
  • 70166-059 Bismuth Subsalicylate 262 mg/15ml Oral Liquid by Lohxa

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 36800-710 QR Code

< Prev: 36800-709Next: 36800-711 >

Related Discussions:

composition of bismuth subsalicylate drug
This is a drug which is used for diarrhea,a antidiarrheal drug...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.